REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 91 filers reported holding REVOLUTION MEDICINES INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,691,438 | -17.9% | 97,234 | -20.6% | 0.00% | 0.0% |
| Q2 2023 | $3,277,517 | -42.6% | 122,524 | -53.5% | 0.00% | -50.0% |
| Q1 2023 | $5,713,215 | +124.4% | 263,768 | +146.8% | 0.00% | +100.0% |
| Q4 2022 | $2,546,167 | -47.3% | 106,892 | -56.4% | 0.00% | -33.3% |
| Q3 2022 | $4,834,000 | +126.4% | 245,145 | +123.8% | 0.00% | +50.0% |
| Q2 2022 | $2,135,000 | +192.9% | 109,547 | +283.6% | 0.00% | – |
| Q1 2022 | $729,000 | -78.7% | 28,560 | -79.0% | 0.00% | -100.0% |
| Q4 2021 | $3,420,000 | +69.6% | 135,858 | +85.4% | 0.00% | +100.0% |
| Q3 2021 | $2,016,000 | -48.1% | 73,294 | -40.1% | 0.00% | -50.0% |
| Q2 2021 | $3,882,000 | -7.0% | 122,317 | +34.4% | 0.00% | -33.3% |
| Q1 2021 | $4,175,000 | +906.0% | 91,003 | +768.6% | 0.00% | – |
| Q4 2020 | $415,000 | +377.0% | 10,477 | +318.4% | 0.00% | – |
| Q3 2020 | $87,000 | -33.6% | 2,504 | -39.7% | 0.00% | – |
| Q2 2020 | $131,000 | +45.6% | 4,152 | +0.7% | 0.00% | – |
| Q1 2020 | $90,000 | – | 4,123 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nextech Invest Ltd. | 4,839,529 | $133,958,163 | 40.59% |
| Column Group LLC | 1,230,641 | $34,064,143 | 22.62% |
| Boxer Capital, LLC | 4,684,264 | $129,660,428 | 6.90% |
| Finepoint Capital LP | 427,000 | $11,819,360 | 5.89% |
| Casdin Capital, LLC | 1,810,000 | $50,100,800 | 5.54% |
| EcoR1 Capital, LLC | 5,577,863 | $154,395,248 | 5.21% |
| DAFNA Capital Management LLC | 473,394 | $13,103,546 | 4.08% |
| Artal Group S.A. | 2,529,737 | $70,023 | 3.00% |
| BVF INC/IL | 3,981,212 | $110,199,948 | 2.97% |
| Bellevue Group AG | 4,721,500 | $130,691,120 | 2.11% |